Interpharm Holdings Stock Forecast - Relative Strength Index
| IPAH Stock | USD 0 0.00 0.00% |
Interpharm Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Interpharm Holdings' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 23rd of January 2026 the relative strength index (rsi) of Interpharm Holdings' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Revenue Growth (0.07) |
Using Interpharm Holdings hype-based prediction, you can estimate the value of Interpharm Holdings from the perspective of Interpharm Holdings response to recently generated media hype and the effects of current headlines on its competitors.
Interpharm Holdings after-hype prediction price | USD 0.0041 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Interpharm | Build AI portfolio with Interpharm Stock |
Interpharm Holdings Additional Predictive Modules
Most predictive techniques to examine Interpharm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Interpharm using various technical indicators. When you analyze Interpharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Interpharm Holdings Volatility | Backtest Interpharm Holdings | Information Ratio |
Interpharm Holdings Trading Date Momentum
| On January 23 2026 Interpharm Holdings was traded for 0 at the closing time. The top price for the day was 0 and the lowest listed price was 0 . There was no trading activity during the period 0.0. Lack of trading volume on January 23, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
| Compare Interpharm Holdings to competition |
Other Forecasting Options for Interpharm Holdings
For every potential investor in Interpharm, whether a beginner or expert, Interpharm Holdings' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Interpharm Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Interpharm. Basic forecasting techniques help filter out the noise by identifying Interpharm Holdings' price trends.Interpharm Holdings Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Interpharm Holdings stock to make a market-neutral strategy. Peer analysis of Interpharm Holdings could also be used in its relative valuation, which is a method of valuing Interpharm Holdings by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Interpharm Holdings Market Strength Events
Market strength indicators help investors to evaluate how Interpharm Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Interpharm Holdings shares will generate the highest return on investment. By undertsting and applying Interpharm Holdings stock market strength indicators, traders can identify Interpharm Holdings entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0041 | |||
| Day Typical Price | 0.0041 |
Story Coverage note for Interpharm Holdings
The number of cover stories for Interpharm Holdings depends on current market conditions and Interpharm Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Interpharm Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Interpharm Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Historical Fundamental Analysis of Interpharm Holdings to cross-verify your projections. For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Interpharm Holdings. If investors know Interpharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Interpharm Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
The market value of Interpharm Holdings is measured differently than its book value, which is the value of Interpharm that is recorded on the company's balance sheet. Investors also form their own opinion of Interpharm Holdings' value that differs from its market value or its book value, called intrinsic value, which is Interpharm Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Interpharm Holdings' market value can be influenced by many factors that don't directly affect Interpharm Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Interpharm Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Interpharm Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpharm Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.